Slash Fatty Liver Signs in 8 Weeks
Some health issues are glaringly obvious—like that pain in your joints or the ringing in your ears.
But it’s the silent ones that can cause the most damage.
Non-alcoholic fatty liver disease (NAFLD) falls into this silent-but-deadly category.
The buildup of fat in your liver can lead to liver damage, cancer, and other serious health problems.
The good news is that if you’re among the 25 percent of U.S. adults who have NAFLD, a surprising over-the-counter fix could significantly reduce the fat in your liver in as little as eight weeks.
In a randomized, double-blind trial, 57 people with NAFLD took either a probiotic or a placebo daily for eight weeks.
(The probiotic contained 1.66 billion CFUs of Bacillus coagulans TC1711.)
Using a liver fibrosis scanner to measure liver fat, the researchers determined that the volunteers taking the probiotic reduced the fat content in their livers by a healthy 5.2 percent in just eight weeks.
And participants with a BMI of less than 30 experienced an even more significant 8.7 percent reduction.
But as incredible as those results are, the benefits didn’t end there.
Folks taking the probiotic also had a significant increase in several other beneficial bacteria in their gut, including…
- Bifidobacterium,
- Eubacterium,
- and Sellimonas.
The increase in beneficial Bifidobacterium is especially significant here since it can inhibit liver inflammation and fat accumulation.
Eubacterium helps regulate liver inflammation, and Sellimonas helps regulate intestinal metabolic balance.
This study confirms what I’ve said all along. You DON’T always need Big Pharma’s pricey, side-effect-laden solutions to get the job done.
Instead, something as simple as taking a probiotic can help address a significant health threat tens of thousands of people face (whether they realize it or not).
P.S. Help tackle fatty liver BEFORE it becomes a problem with this surprising grocery store solution.
SOURCE:
Rong-Hong Hsieh, et al., “Bacillus coagulans TCI711 Supplementation Improved Nonalcoholic Fatty Liver by Modulating Gut Microbiota: A Randomized, Placebo-Controlled, Clinical Trial.” Current Developments in Nutrition, VOL 8, Issue 3, 102083, MARCH 2024, [doi. org /10. 1016/j.cdnut. 2024.102083]
